ACSR and Proscia Concentriq on the Web
We are thrilled to announce ACSR’s highly valued relationship with Proscia®. Read the full release below for more on how enterprise digital pathology thru Proscia Concentriq is helping the ACSR …
NEW from NCI Minute: ComboMatch
Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH …
Congratulations, Dr. Monica Bertagnolli, NIH Director
The ACSR congratulates Dr. Monica Bertagnolli as she takes the helm as the 17th NIH Director! She is the first surgeon and the second woman to hold the position. Nominated …
Registration Now! Global Oncology Symposium on Oncogenic Viruses
City of Hope’s, in person and virtual, Global Oncology Symposium on Oncogenic Viruses will take place Fri, Oct 27, 8 a.m.-3:30 p.m. PDT. The symposium promises to cover a comprehensive …
Tackling cancer globally requires research commitments in LMICs- S. Gopal
Read “Tackling cancer globally requires research commitments in LMICs”, the latest Worldview Editorial in Nature written by Dr. Satish Gopal, Director of the National Cancer Institute’s Center for Global Health. …
Biden Awards $5.4 Million Inaugural Cohort of Cancer Moonshot Scholars
The Biden-Harris Administration, through NCI, is committing $5.4 million in the first year of these multi-year awards to support the inaugural cohort of 11 Cancer Moonshot Scholars. The inaugural cohort …
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
From Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings NOT-CA-23-078 NCI encourages applications for pragmatic clinical trials to generate evidence that directly informs decision-making among patients, providers, …
New Funding: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health
From RFA-CA-24-005 This Notice of Funding Opportunity (NOFO) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the NOFO solicits applications for projects …
A Single Dose Of HPV Vaccine May Provide Adequate Protection
NEW from the Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc. for the National Cancer Institute. Recent research adds to growing evidence that a single dose …
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Through this Notice of Special Interest (NOSI), NOT-CA-23-070 the National Cancer Institute (NCI) is a continuation of NOT-CA-20-022, “High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers, which expired …